According to a new study, practicing yoga or meditation can help reduce healthcare costs by as much as 50 per cent for the people.
The study conducted by researchers at the Harvard-affiliated Massachusetts General Hospital Institute for Technology Assessment and the Benson-Henry Institute, showed that yoga and meditation can keep you healthy and reduces spending on healthcare. The study said that the practices like relaxation response or deep rest can help avoid stress and anxiety and help maintain a healthy heart rate and blood pressure.
Researcher James E Stahl said, “Our study's primary finding is that programs that train patients to elicit the relaxation response can also dramatically reduce health care utilisation. These programs promote wellness and in our environment of constrained health care resources, could potentially ease the burden on our health delivery systems at minimal cost and at no real risk.”
The researchers conducted a comparative study of data available on Research Patient Data Registry (RPDR) of Partners HealthCare and data on individuals participating in the BHI Relaxation Response Resiliency Program (3RP) from the year 2006 to 2014. They found that practitioners of yoga, meditation, prayer spent a much lower amount on medical costs compared to those who did not practice.
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
In a blog post published on Wednesday, Twitter-owned...
A draft New York legislation proposes the use of a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).